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Abstract
The CNS is a unique organ due to its limited capacity for immune surveillance. As macrophages of the CNS, microglia
represent a population originally known for the ability to assist neuronal stability, are now appreciated for their role in
initiating and regulating immune responses in the brain. Theiler’s murine encephalomyelitis virus (TMEV)-induced
demyelinating disease is a mouse model of multiple sclerosis (MS). In response to TMEV infection in vitro, microglia produce
high levels of inflammatory cytokines and chemokines, and are efficient antigen-presenting cells (APCs) for activating CD4
+
T cells. However, the regulatory function of microglia and other CNS-infiltrating APCs in response to TMEV in vivo remains
unclear. Here we demonstrate that microglia increase expression of proliferating cell nuclear antigen (PCNA), and
phenotypically express high levels of major histocompatibility complex (MHC)-Class I and II in response to acute infection
with TMEV in SJL/J mice. Microglia increase expression of the inhibitory co-stimulatory molecule, B7-H1 as early as day 5
post-infection, while CNS-infiltrating CD11b
+CD11c
2CD45
HIGH monocytes/macrophages and CD11b
+CD11c
+CD45
HIGH
dendritic cells upregulate expression of B7-H1 by day 3 post-infection. Utilizing a neutralizing antibody, we demonstrate
that B7-H1 negatively regulates TMEV-specific ex vivo production of interferon (IFN)-c, interleukin (IL)-17, IL-10, and IL-2 from
CD4
+ and CD8
+ T cells. In vivo blockade of B7-H1 in SJL/J mice significantly exacerbates clinical disease symptoms during the
chronic autoimmune stage of TMEV-IDD, but only has minimal effects on viral clearance. Collectively, these results suggest
that CNS expression of B7-H1 regulates activation of TMEV-specific T cells, which affects protection against TMEV-IDD.
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Introduction
Central nervous system (CNS) infections are a challenge in host
defense and effective pathogen clearance due to the lack of
lymphatic drainage and minimal immune surveillance [1,2]. It is
well-established that CNS-resident microglia serve as a critical cell
type for host defense, capable of initiating and regulating rapid
responses against infections [2]. Due to their innate (cytokine and
chemokine secretion) and adaptive (phagocytosis and T cell
activation) immune functions, microglia serve as the first line of
host defense in the CNS, necessary for recruitment and activation
of infiltrating effector immune cells [3].
Theiler’s murine encephalomyelitis virus-induced demyelinat-
ing disease (TMEV-IDD) is a virus-induced experimental mouse
model of the human disease, multiple sclerosis [4]. TMEV is a
single-stranded RNA virus, and intracranial inoculation of
susceptible mouse strains (SJL/J) leads to the development of a
chronic-progressive CD4
+ T cell-mediated demyelinating disease
[4,5,6]. As TMEV-IDD progresses, epitope spreading gives rise to
CD4
+ T cell responses against myelin peptides, proteolipid protein
(PLP)139–151, PLP56–70, myelin oligodendrocyte glycoprotein
(MOG92–106), PLP178–191, and myelin basic protein (MBP84–104)
[5,7]. TMEV persistently infects astrocytes, microglia, peripheral
macrophages and dendritic cells [5,6,8], as well as stimulates
microglial production of tumor necrosis factor (TNF-a), interleu-
kin (IL)-6, IL-1b, IL-23p19, IL-12p70, CCL2, CCL3, CCL5, and
CXCL10 in vitro [8,9,10]. Additionally, microglia and CD11b
+F4/
80
+CD45
HIGH macrophages robustly increase cell surface expres-
sion of major histocompatibility complex (MHC) class I and MHC
class II, costimulatory molecules (CD80, CD86, and CD40), and
are efficient antigen presentation cells (APCs) stimulating prolif-
eration and interferon (IFN)-c secretion of virus-specific CD4
+ T
cells [9,10,11,12]. These studies support a role of microglia and
macrophages as a functional APCs in virus-induced inflammation
and demyelination. However, the mechanism(s) by which CNS-
resident and -infiltrating APCs regulate effector T cell responses in
acute TMEV infection have yet to be explored.
Mechanisms exist between T cells and infected APCs, which
elicit T cell dysfunction during viral infections. Negative co-
stimulatory molecules, belonging to the B7:CD28 family, pro-
grammed death receptor-1 (PD-1) and its ligands, programmed
death-ligand 1 (B7-H1/PD-L1) and programmed death-ligand 2
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18548(B7-DC/PD-L2) inhibit effector T cell responses [13,14]. B7-H1 is
constitutively expressed on T and B cells, and is increased upon
stimulation with interferon (IFN-c) and IFN-b [15]. Microglia,
astrocytes, oligodendrocytes, and neurons all express constitutive
levels of B7-H1, which is upregulated upon IFN-c stimulation
[15,16,17,18]. Signaling between B7-H1:PD-1 leads to an
‘‘exhausted’’ T response, characterized by decreased proliferative
capacity, cytokine secretion, and cytotoxic effector functions [19].
Functional blockade of these interactions enables increased
effector T cell function during viral infection [19], in contrast, in
models of CNS autoimmunity, these interactions are reported to
dampen autoreactive T cell responses protecting the CNS [15,16].
To date, few studies have examined the function of the B7-
H1:PD-1 pathway in CNS infections. Infection with the JHM
strain of mouse hepatitis virus (JHMV), leads to transient
expression of B7-H1 by microglia, but higher, sustained expression
by oligodendrocytes; suggesting cell-type specific regulation of B7-
H1 in CNS infections [17]. Additionally, neuronal expression of
B7-H1 limits persistence of rabies virus, leading to protection
against infection [18]. Thus, we hypothesized that B7-H1 signaling
by microglia and other CNS-infiltrating APCs are critical for the
regulation of virus specific effector T cell function, which may
dampen the immune response to TMEV infection in vivo.
In this report, we describe phenotypic and effector functions of
microglia in acute in vivo infection of SJL/J mice with TMEV.
Microglia display differential expression patterns of antigen
presentation molecules, I-A
s, H-2K
s, CD80, CD86, but express
elevated and sustained levels of B7-H1 as early as day 3 post-
infection compared to sham-infected microglia. CNS-infiltrating
CD11b
+CD11c
2 monocytes/macrophages and CD11b
+CD11c
+
dendritic cells highly express B7-H1 compared to microglia
following TMEV infection. Ex vivo blockade of B7-H1 on
TMEV-infected mononuclear cells enhances IFN-c/IL-17 and
IFN-c production from CD4
+ and CD8
+ T cells, respectively.
Blockade of B7-H1 in virus-infected SJL/J mice leads enhanced
severity of TMEV-IDD during the chronic autoimmune phase of
disease, although mice that received anti-B7-H1 neutralizing
antibodies have only slightly elevated virus levels in the brain.
These data are the first to demonstrate a role for B7-H1 in
regulating virus-specific effector T cell response in the CNS
thereby limiting TMEV-IDD in vivo.
Materials and Methods
Mice
Female SJL/J mice (5–6 weeks) were purchased from Harlan
Labs (Indianapolis, IN). All mice were housed under specific
pathogen-free conditions in the Northwestern University CCM
facility (Animal Welfare Assurance Number A3283-01) and
experiments performed according to Protocol 2007-1285 ap-
proved by the Northwestern University Animal Care and Use
Committee.
Induction of TMEV-IDD
Mice were anesthetized with isoflurane (Bulter Animal Health
Supply; Dublin, OH) and intracranially inoculated in the right
cerebral hemisphere with 3610
7 plaque forming units (PFU) of the
BeAn strain 8386 of TMEV in 30 ml serum-free Dulbecco’s
Modified Eagle’s Medium (DMEM). Mice were examined two to
three times per week for the development of chronic gait
abnormalities and spastic paralysis indicative of demyelination,
and assigned a clinical score of 0 to 6 as follows: 0=asymptomatic,
1=mild waddling gait, 2=severe waddling gait, intact righting
reflex, 3=severe waddling gait, spastic hind limb paralysis,
impaired righting reflex, 4=severe waddling gait, spastic hind
limb paralysis, impaired righting reflex, mild dehydration and/or
malnutrition, 5=total hind limb paralysis, severe dehydration
and/or malnutrition, 6=death.
CNS Mononuclear Cell Isolation
Mice were anesthetized, transcardially perfused with phosphate
buffered saline (PBS), and CNS cells were isolated as described
previously [20], with the following adjustments. After digestion
with DNAse I (Sigma Aldrich; St. Louis, MO) and Liberase
(Roche Molecular Biochemicals; Indianapolis, IN), softened tissue
was pushed through a 40 mM metal cell strainer.
Flow Cytometry and Antibodies
Single cell suspensions for analysis were blocked with 10% rat
serum, 10% mouse serum and antiCD16/32 for 20 minutes at
4uC before staining with multicolor antibody cocktails. Directly
conjugated antibodies specific for mouse antigens CD3 (145-2C11;
1:150), CD4 (GK1.5; 1:150), CD8 (53-6.7; 1:150), CD11b (M1/
70; 1:200), CD11c (N418; 1:150), CD45 (30-F11; 1:250), CD80
(16-10A1; 1:150), CD86 (GL1; 1:150), CD40 (HM40.3; 1:150), H-
2K (KH49; 1:150), I-A (KH116; 1:150), B7-H1 (MIH5; 1:150),
and PD-1 (J43; 1:150) were purchased from BD Pharmingen or
eBioscience (San Diego, CA). Proliferating cell nuclear antigen-
FITC (PCNA) used at a 1:100 dilution was purchased from
DakoCytomation. Biotinylated anti-I-A
s (MKS4) was labeled with
streptavidin-PeCy7 (eBioscience). Isotype antibodies for individual
staining antibodies were used to define positive and negative
staining. Data were acquired on a FACS CANTO cytometer (BD;
Sparks, MD) and analyzed using Flow Jo (Treestar; Ashland, OR)
software.
Neutralization of B7-H1 Signaling
CNS mononuclear cells were isolated from sham- and TMEV-
infected tissue. Bulk cells were seeded at a cell density of 1610
5/
well and co-cultured in the presence of 10 mM Rat IgG2a (isotype
control) or anti-B7H1 monoclonal Ab (mAb; clone MIH5,
eBioscience, San Diego, CA) and 0 or 50 mM VP270–86 (CD4
+
immundominant peptide: WTTSQEAFSHIRIPLPH) or VP3159–
166 (CD8
+ immundominant peptide: FNFTAPFI; Genemed
Synthesis, Inc., South San Francisco, CA). Cells were cultured
in RPMI (Sigma Aldrich, St. Louis, MO) with 10% fetal bovine
serum (FBS), 2 mM L-glutamine (Life Technologies, Gaithers-
burg, MD), 100 U/mL penicillin (Life Technologies), 100 mg/mL
streptomycin (Life Technologies), 0.1 mM non-essential amino
acids (Sigma Aldrich), 50 mM 2-mercaptoethanol, 25 mM
HEPES (Mediatech, Masnassas, VA), 1 mM aminoguanidine
(Sigma Aldrich) and 20 mM indomethacin (Sigma Aldrich) to
suppress nitric oxide synthetase and prostaglandin production.
Cultures of CNS cells alone and CNS cells stimulated with aCD3
(Clone 2C11; Bio X Cell; West Lebanon, NH) served as negative
and positive controls, respectively. Following 72-hour incubation
at 37uC, culture supernatants were collected and stored at 220uC
until analysis. Cytokines and chemokines (IL-2, IFNc, IL-17, IL-
10) were measured from cultured supernatants and analyzed using
the CBA Cell Signaling Flex Kit (BD Biosciences). Data
acquisition from samples was collected using a FACS CANTO
cytometer and analyzed using the FCAP Array Software (BD
Biosciences).
In vivo Blockade of B7-H1
To determine the function of B7-H1 on the development and
severity of TMEV-IDD in vivo, female SJL/J mice were
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Bio X Cell, West Lebanon, NH) or aB7-H1 (clone 10F.9G2; Bio
X Cell, West Lebanon, NH) at days 0 and
+3 (relative to infection)
and monitored for clinical signs of disease.
TMEV plaque assay
Brains and spinal cords from Rat IgG2a and aB7-H1 treated
mice at days 7 and 14 post-infection were collected from
anesthetized mice, weighed, and homogenized on ice using a
Polytron System PT1200C tissue homogenizer (Kinematica AG,
Switzerland). CNS homogenates were serially diluted and added
to tissue culture-treated plates (Nunc, Roskilde, Denmark) of
confluent BHK-21 cells (American Type Culture Collection,
Manassas, VA) for a 1 h incubation at room temperature, with
periodic gentle rocking. A media/agar solution containing 1%
Noble Agar (BD, Sparks, MD) and 26DMEM was added to cells
after the 1 h incubation. Following a 5 day incubation at 34uC,
formalin (Fisher Scientific, Fair Lawn, NJ) was added and
incubated at room temperature for 1 h to fix the BHK monolayer.
The agar was removed from the plates and plaques were visualized
by staining with crystal violet. To determine PFU/ml homogenate,
the number of plaques on each plate was multiplied by the dilution
factor of the homogenate and divided by the amount of
homogenate added per plate. The PFU/ml was divided by the
weight of the tissue to calculate PFU/g tissue.
Statistical Analyses
Comparisons were performed using two-tailed Student’s t-test.
Comparisons of more than two groups were analyzed using a two-
way ANOVA. Two-way ANOVA with a Bonferroni post-test was
used to determine statistical differences between mean clinical
disease scores.
Results
TMEV infection stimulates an increase in microglia cell
numbers and PCNA expression
The contribution of microglia to initiate CNS innate and
adaptive immune responses to TMEV infection has been
extensively studied in vitro [8,9]. Further, our laboratory has
previously demonstrated that microglia display a similar pheno-
type and function to CNS-infiltrating macrophages during chronic
TMEV-IDD in vivo [10]. To further study the function of this cell
type during the innate in vivo antiviral responses against TMEV,
we examined immune functions of microglia in acute TMEV
infection. We first quantified the total number of microglia from
the brains and spinal cords of sham- and TMEV-infected at days
3, 5, and 7 post-infection. As shown in Figure 1A, TMEV
infection induced increased microglia cell numbers as early as day
5 post-infection, and the numbers remained elevated at day 7 post-
infection. Thus, acute TMEV infection enhances the expansion of
microglia in vivo.
Figure 1. TMEV infection induces increased microglia cell
numbers associated with elevated levels of PCNA expression.
A. Microglia were isolated from sham-infected and TMEV-infected SJL/J
mice at day 3, 5, and 7 post-infection and identified by CD11b and
CD45 expression via flow cytometric analysis using the illustrated
gating strategy. The data is representative of 2–3 independent
experiments with an average of 3–5 mice per group per experiment.
B. The percentage of cells expression Proliferation Cell Nuclear Antigen
(PCNA) was measured in microglia (CD11b
+CD45
LOW) isolated during
the acute phase of TMEV infection using flow cytometry. C. Mean
Fluorescence Intensity (MFI) of PCNA expression in microglia isolated
from TMEV-infected mice compared to sham-infected mice. Microglia
isolated from LPS-treated mice (200 mg/for 15 hours) served as a
positive control. These data are representative of four independent
experiments with n=4–5/group expressed as the average 6 SEM.
doi:10.1371/journal.pone.0018548.g001
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following Theiler’s virus infection. Murine microglia undergo rapid
proliferation and migrate to sites of CNS injury and infection in vivo.
To quantify the proliferation, we examined the expression of
proliferating cell nuclear antigen (PCNA), an intracellular protein
thatisabundantinallcellsandaccumulatesintheSphaseofthecell
cycle [21], using flow cytometry. Expression of PCNA by microglia
isolated from sham- and TMEV-infected mice was analyzed at days
3, 5, and 7 post-infection.As demonstrated in Figure1B, microglia
upregulate PCNA expression as early as day 3 post-infection
compared to microglia from sham-infected mice (13.7563.35% vs.
7.1362.47%) with the most significant increase observed at day 7
post-infection (35.0762.56% vs. 14.0564.85%). The mean fluo-
rescence intensity also correlates with the overall increased
percentages of PCNA
+ microglia, with the most significant increase
at day 7 (430.33647.70 vs. 250.506161.50) (Figure 1C). These
data indicate that microglia respond rapidly to TMEV infection by
increasing in number and expression of PCNA.
Microglia and CNS-Infiltrating APCs express differential
levels of antigen presentation molecules after TMEV
infection
Microglia constitutively express negative to low levels of B7-1
(CD80), B7-2 (CD86), and major histocompatibility complex
(MHC) molecules. Expression of these molecules is upregulated in
response to inflammatory and TMEV virus stimuli in vitro and ex
vivo [9,11,12]. Additionally, the negative costimulatory molecule,
B7-H1, is constitutively expressed by microglia and is increased
following stimulation with IFN-c and IFN-b [15,16,17,18].
Therefore, we examined the expression of antigen presentation-
related molecules by microglia following acute TMEV infection in
vivo. Microglia were isolated from TMEV- and sham-infected mice
and assessed for the expression levels of MHC class I (H-2K
s),
MHC Class II (I-A
s), CD80, CD86, and B7-H1 using flow
cytometry. Similar to previous in vitro findings, the percentage of
microglia from TMEV-infected mice upregulating MHC class I
expression was significantly greater than those from sham-infected
mice at all time-points post-infection reaching 54.0364.184% by
day 7 post-infection (Figure 2A&B). In contrast to MHC class I,
MHC Class II expression by TMEV-infected microglia was
significantly delayed, as enhanced expression was only evident at
day 7 post-infection (13.864.038%) compared to sham-infected
microglia (1.5560.431%) (Figure 2C&D).
The inducible expression of positive and negative costimulatory
molecules (CD80, CD86, B7-H1) by microglia was also examined
following infection to gain further insight into their function during
acute TMEV infection in vivo. TMEV significantly induces CD80
expression on microglia peaking at day 3 post-infection
(21.4062.57% vs. 3.460.37%) (Figure 3A&B). CD86 expression
was similarly upregulated (Figure 3C&D). The differential expres-
sion of B7-H1 on microglia in response to inflammation [15,16]
raised the possibility that B7-H1:PD-1 interactions may play a pivotal
role in regulating the initiation and duration of anti-TMEV responses
in vivo. Therefore, we examined the expression patterns of B7-H1 by
microglia from uninfected and TMEV-infected mice. Approximately
25% of microglia from TMEV-infected mice expressed are B7-H1
+
within 3 days post-infection and the increased expression remained at
day 7 post-infection (Figure3E&F). In terms ofthe expression of B7-
H1 by CNS-infiltrating CD45
HIGHCD11b
+CD11c
2 macrophages
and monocytes or CD45
HIGHCD11b
+CD11c
+ conventional den-
dritic cells, CD11b
+CD11c
+ cells displayed significant enhanced
expression of B7-H1 (Day 3: 67.73361.462%; Day 5:
86.23362.034%; Day 7: 85.70061.550%) compared to
CD11b
+CD11c
2 (Day 3: 51.861.677%; Day 5: 55.43363.811%;
Day 7: 69.83363.524%) cells at all time-points following acute
TMEV infection (Figure 4A–C). Consistent with previous findings
[15], expression of B7-DC (B7-H2, a secondary ligand for PD-1) by
microglia was undetectable, while expression was restricted to
dendritic cells and macrophages following TMEV infection (data
not shown). These data suggest microglia and CNS-infiltrating
CD11b
+CD11c
+/2APCs may becriticalfor effector T cellregulation
due to elevated and sustained levels of B7-H1 during acute CNS
encephalitis induced by TMEV infection.
CD8
+ T cells express high levels of B7-H1 and PD-1 in
response to TMEV infection in vivo
Naı ¨ve CD4
+ and CD8
+ T cells express constitutive low levels of
B7-H1, but expression remains high during chronic viral infections
[19]. Activated T cells and ‘‘exhausted’’ CD8
+ T cells express PD-
1 [19]. B7-H1 and PD-1 expression was assessed on CD4
+ and
CD8
+ T cells isolated from the CNS to determine their potential
role in regulation of CNS-infiltrating effector T cell function at the
site of infection. Both CD4
+ and CD8
+ T cells express similar
levels of B7-H1 at day 7 post-infection (Figure 5A) (90.3%
+ vs.
98.9%
+), while CD8
+ T cells express elevated levels of PD-1
represented by percent positive (48.8%
+ vs. 57.2%
+) and mean
fluorescence intensity (Figure 5B)( B7-H1: 335.40639.451
[CD4
+ T cells] vs. 886.8632.772 [CD8
+ T cells]; (PD-1:
553.668.992 [CD4
+ T cells] vs. 363.30655.310 [CD8
+ T cells]).
The expression of B7-H1 and PD-1 on T cells decreased by day 14
post-infection (data not shown). These data highlight a potential
mechanism by which CD8
+ T cells can be impaired to perform
effector functions, such as IFN-c production, leading to an
ineffective immune response to TMEV-IDD allowing the
establishment of a persistent CNS TMEV infection.
B7-H1 signaling regulates TMEV-specific CNS CD4
+ and
CD8
+ T cell effector function
PD-1:B7-H1 interactions inhibit T cell activation [14,22],
ultimately resulting in decreased proliferation and effector cytokine
production i.e. IFN-c [19]. To determine if B7-H1 signaling
hampers CD4
+ T cell function, CNS mononuclear cells isolated
from sham- and TMEV-infected mice were stimulated in the
absence or presence of VP270–86 and anti-B7-H1 monoclonal
antibody (mAb). Blockade of B7-H1 signaling did not affect the
proliferation of CNS-infiltrating VP270–86 CD4
+ T cells
(Figure 6A). However inhibition of B7-H1 signaling led to
increased production of IL-17, IFNc, and IL-2 in a VP270–86 dose-
dependent manner (Figure 6B–D). To determine if B7-H1
signaling down-regulates CD8
+ T cell function, CNS mononuclear
cells isolated from sham- and TMEV-infected mice were
stimulated in the absence or presence of VP3159–166 and anti-
B7-H1 mAb. Similar to CD4
+ T cell responses, inhibition of B7-
H1:PD-1 signaling enhanced production of IFN-c and IL-2 in a
VP3159–166 dose-dependent manner (Figure 7A&B). Unlike
CD4
+ T cells, we did not observe production of IL-17 from
VP3159–166-stimulated CD8
+ T cells following treatment with
isotype or anti-B7-H1 (data not shown). These data demonstrate
that B7-H1:PD-1 signaling inhibits effector cytokine production by
CNS-infiltrating CD4
+ and CD8
+ T cells, further supporting a
regulatory function of this receptor:ligand pair in controlling T cell
effector functions against TMEV infection in vivo.
B7-H1 negatively regulates the progression of chronic
TMEV-IDD
Elevated and sustained levels of B7-H1 by CNS-resident
microglia and CNS-infiltrating T cells support a role for B7-
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PLoS ONE | www.plosone.org 4 April 2011 | Volume 6 | Issue 4 | e18548Figure 2. TMEV induces differential expression of antigen presentation molecules on microglia in vivo.A . Microglia (CD11b
+CD45
LOW)
from sham- and TMEV-infected mice at days 3, 5, and 7 post-infection and analyzed for H-2K
s and I-A
s expression using flow cytometry. A&B.
Histograms are representative of H-2K
s expression. B. Quantification of percent positive for H-2K
s are reflected based of negative staining from
isotype controls and sham-infected microglia. C&D. Histograms are representative of I-A
s expression. Quantification of percent positive for I-A
s are
reflected based of negative staining from sham-infected microglia. The data is representative of three independent experiments with n=4–5 mice/
group expressed as the average 6 SEM. *p,0.05 compared to sham-infected mice.
doi:10.1371/journal.pone.0018548.g002
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potentially regulating onset and progression of TMEV-IDD in vivo.
To further support this hypothesis, the development of TMEV-
IDD was compared in anti-B7-H1 mAb-treated and control Ig-
treated control mice. The onset of clinical symptoms of TMEV-
IDD was comparable in anti-B7-H1 mAb and control mice
(Figure 8), however the severity of clinical disease was
significantly increased in the chronic phase of disease (.day 55–
60 post-infection) and this was also reflected by histopathological
examination of inflammation and demyelination (data not shown).
Figure 3. TMEV induces differential expression of positive and negative co-stimulatory molecules on microglia in vivo.A . Microglia
(CD11b
+CD45
LOW) from sham- and TMEV-infected mice at days 3, 5, and 7 post-infection were analyzed for CD80, CD86, and B7-H1 expression using
flow cytometry. A&B. Histograms are representative of CD80 expression. C&D. Histograms are representative of CD86 expression. E&F. Histograms
are representative of B7-H1 expression. The data is representative of three independent experiments with n=4–5 mice/group expressed as the
average 6 SEM. *p,0.05 compared to sham-infected mice.
doi:10.1371/journal.pone.0018548.g003
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PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e18548Viral clearance of TMEV was also assessed following treatment
with anti-B7-H1 mAb. TMEV viral loads in the brain remained
similar between anti-B7-H1 mAb and control treated mice at day
7 and day 14 post-infection (Figure 9). Although B7-H1 and
PD-1 expression is observed on CNS-resident microglia and CNS-
infiltrating T cells, anti-B7-H1 mAb treatment does not signifi-
cantly alter the viral clearance and onset of disease, but does
increase the severity of TMEV-IDD in vivo indicating an important
role for this molecule in regulating the chronic autoimmune phase
of disease.
Discussion
CNS infections represent a unique challenge to the host due to
the relative paucity of surveillance by peripheral immune cells.
Thus, understanding the immune functions of microglia and other
CNS-resident cells during CNS infections is critical for promoting
host defense and clearance of the infection [1,2]. Infection with
TMEV, a single-stranded RNA virus, leads to a chronic
progressive demyelinating disease in susceptible mouse strains
associated with persistent CNS virus infection and serves as an
relevant experimental mouse model of MS. In the present study,
we examined the effector functions of microglia in response to
acute TMEV infection in vivo, and focused on understanding a
potential mechanism by which the negative co-stimulatory
molecule B7-H1 regulates virus-specific T cell responses and
may contribute to the induction of chronic autoimmune
demyelination.
We have described temporal and phenotypic characteristics of
microglia after TMEV infection. Microglia cell numbers increase
over time in response to TMEV infection in vivo (Figure 1),
suggesting these cells are the first responders cells with the ability
to proliferate and migrate to the site of infection [3]. Due to the
increase in microglial cell numbers following TMEV infection, we
hypothesized that microglia were proliferating in situ or a
peripheral monocyte/macrophage population may be contribut-
ing to the overall increase in cell numbers. Using flow cytometric
analyses, microglia increase expression of the nuclear cell-cycle
protein, PCNA in response to TMEV infection with peak
expression observed at day 7 post-infection (Figure 1). To
distinguish between a peripheral immune cell population infiltrat-
ing and differentiating into microglia after TMEV infection, we
also examined the expression of Ly6C, a marker of ‘‘inflammatory
monocytes’’ using flow cytometry [23]. Our results indicate that
microglia were Ly6C
LOW suggesting that microglia were prolifer-
ating in the CNS, and a peripheral monocyte/macrophage
population was not contributing to the microglia pool in
TMEV-IDD in vivo (data not shown).
Our laboratory has extensively studied the innate immune
functions of neonatal microglia in vitro. Upon TMEV infection,
Figure 4. Expression of B7-H1 by CNS-Infiltrating APCs following TMEV infection in vivo. CNS-infiltrating APCs from TMEV-infected mice
at days 3, 5 and 7 post-infection were analyzed for B7-H1 expression. A. Gating strategy identifying CD11b
+CD11c
2 monocytes/macrophages and
CD11b
+CD11c
+ dendritic cells based on CD45
HIGH expression to exclude microglia. Numbers reflect total percentages of each cell population. B.
Histograms of B7-H1 expression on monocyte/macrophage and dendritic cell populations following infection. C. Quantification of percent positive
for B7-H1 are reflected based of negative staining from isotype controls and sham-infected cell populations. Black bars represent CD11b
+CD11c
2
monocytes/macrophages, while white bars reflect CD11b
+CD11c
+ dendritic cells. The data is representative of three independent experiments with
n=4–5 mice/group expressed as the average 6 SEM. **p,0.01, ***p,0.001 compared to CD11b
+CD11c
2 infiltrating populations.
doi:10.1371/journal.pone.0018548.g004
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PLoS ONE | www.plosone.org 7 April 2011 | Volume 6 | Issue 4 | e18548Figure 5. B7-H1 and PD-1 expression are highly upregulated on CD4
+ and CD8
+ CNS T cells from TMEV-infected SJL/J mice. CNS T
cells from wild-type SJL/J mice at day 7 post-TMEV infection were analyzed for expression of B7-H1 and PD-1 molecules by flow cytometry. A.
Histograms of B7-H1 and PD-1 expression on CD4
+ and CD8
+ T cells. Black shaded area represents isotype control and the grey line represents
positive staining. A representative histogram from one individual mouse from three separate experiments is shown. B. Data is also represented as D
mean fluorescence intensity (DMFI) of B7-H1 and PD-1 expression on CD4
+ and CD8
+ T cells. Expression of B7-H1 and PD-1 is significant greater
(*p,0.05) on with CD8
+ as compared to CD4
+ T cells. Data are expressed as the average 6 SEM.
doi:10.1371/journal.pone.0018548.g005
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PLoS ONE | www.plosone.org 8 April 2011 | Volume 6 | Issue 4 | e18548neonatal microglia produce high levels of TNF-a, IL-6, IFN-a/b,
IL-12p40 compared to uninfected microglia in vitro [8,9].
Additionally, microglia upregulate surface expression of MHC
Class I and MHC Class II, and gain the ability to stimulate
production of IFN-c from TMEV-specific CD4
+ T cells [8,9].
However, the focus of this study was to examine the functions of
microglia isolated from adult mice in vivo, since microglia isolated
from neonatal and adult mice display differential responses to
antigens [24]. In comparison to previous in vitro studies, our data
show that microglia display increased levels of MHC Class I as
early as day 3 post-infection, while increased MHC Class II levels
Figure 7. Blockade of B7-H1 enhances cytokine production
from TMEV-specific CNS-infiltrating CD8
+ T cells ex vivo. CNS
(brain and spinal cord) mononuclear cells were isolated from TMEV-
infected mice (n=10/group) at day 7 post-infection and co-cultured in
the presence of increasing concentrations of the CD8
+ T cell restricted
peptide-VP3159–66. Control Ig (open bars) and anti-mouse B7-H1 (black
bars) were added to the cultures. Unstimulated and anti-mouse CD3-
stimulated CNS mononuclear cells served as negative and positive
controls, respectively. After 72 h, levels of IFN-c (A), and IL-2 (B) were
measured using CBA technology from the supernatants of triplicate
wells. Data are representative of three separate experiments. *p,0.05
compared to cultures containing Rat IgG2a control.
doi:10.1371/journal.pone.0018548.g007
Figure 6. Blockade of B7-H1 enhances cytokine production
from TMEV-specific CNS-infiltrating CD4
+ T cells ex vivo. CNS
(brain and spinal cord) mononuclear cells were isolated from TMEV-
infected mice (n=10/group) at day 7 post-infection and co-cultured in
the presence of the CD4
+ T cell restricted peptide-VP270–86. Control Ig
(open bars) and anti-mouse B7-H1 (black bars) were added to the
cultures. Unstimulated and anti-mouse CD3-stimulated CNS mononu-
clear cells served as negative and positive controls, respectively. A.
Proliferation was analyzed by
3[H]-TdR uptake of triplicate wells per
group. B–D. After 72 h, supernatants from triplicate wells of each group
in (A), the levels of IFN-c (B), IL-17 (C), and IL-2 (D) were measured using
CBA technology. Data are representative of three separate experiments.
*p,0.05 compared to cultures containing rat IgG2a control.
doi:10.1371/journal.pone.0018548.g006
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PLoS ONE | www.plosone.org 9 April 2011 | Volume 6 | Issue 4 | e18548are only most evident at day 7 post-infection in vivo (Figure 2).
Consistent with other studies, these data highlight the differential
regulation of MHC Class I and II expression on microglia during
acute TMEV infection [25], and potentially provide insight into
how these cells may contribute to the reactivation of CNS-
infiltrating CD4
+ and CD8
+ T cells after TMEV infection in vivo.
Microglia also display differences in CD80 and CD86 expression
following TMEV infection in vivo (Figure 3), which differs from
the expression patterns observed with our in vitro studies in that
upregulation is delayed. Our data also indicate that microglia
express elevated and sustained levels of B7-H1 following TMEV
infection, suggesting these cells may be critical for negatively
affecting antiviral T cells responses [15,17,18]. Consistent with
previous findings, increased expression of MHC Class I and
slightly elevated B7-H1 expression by microglia after acute TMEV
infection, suggest that microglia may not be the dominant cell type
contributing to the control of CD8
+ T cell effector function [17]. It
can be hypothesized that CD45
HIGHCD11b
+CD11c
2 CNS-
infiltrating monocytes/macrophages may be more critical for the
regulation of CD8
+ T cell effector function as measured by
significantly higher expression of both MHC Class I and B7-H1
compared to microglia (Figure 4). The possibility of B7-H1:CD80
interactions limiting CD4
+ T cell proliferation and cytokine
secretion has been previously reported [26] and is outside the
scope of our studies. However, it cannot be excluded as an
alternative APC:T cell interaction, contributing to antiviral
mechanisms in TMEV clearance.
Activated T cells express high levels of B7-H1 and PD-1
[14,27]. During TMEV infection, CNS-infiltrating CD4
+ and
CD8
+ T cells express increased levels of B7-H1 and PD-1 at day 7
post-infection, though CD8
+ T cells display significantly higher
levels (Figure 5). Due to enhanced B7-H1 expression in response
to TMEV infection by CNS-resident and -infiltrating APCs and T
cells, we examined a potential mechanism of how this molecule
may regulate cytokine production in our infection model. Our
results indicate that blockade of B7-H1 enhances the production of
IFN-c/IL-17/IL-2 by CD4
+-restricted (VP270–86) and IFN-c/IL-2
by CD8
+-restricted (VP3159–66) T cell responses ex vivo (Figures 6
and 7). Although it has been described that B7-H1 expression is
critical for myeloid DC (CD45
HIGHCD11b
+CD11c
+) regulation of
IFN-c and IL-17 production during autoimmunity [16]; based on
our findings, it remains unclear which APC (microglia, macro-
phages, or subsets of DCs) populations is/are most dominant for
regulating CD4
+ and CD8
+ T cell responses through B7-H1:PD-1
or B7-DC:PD-1 interactions during acute and chronic TMEV-
IDD in vivo.
To date, the functional consequences of B7-H1 inhibition have
been extensively explored in other models of virus-induced
demyelination, such as infection with the JHMV strain of mouse
hepatitis virus (MHV) [17]. Inhibition of B7-H1 significantly
enhances the clinical course of JHMV infection in vivo, without
altering demyelination. Our data indicate that blockade of B7-H1
did not have a significant effect on disease onset, but enhanced the
chronic course of TMEV-IDD during the autoimmune phase of
disease (Figure 8), although mice treated with anti-B7-H1 mAb
have similar TMEV viral loads in the brains at day 7 post-infection
compared to isotype controls (Figure 9). Although our data do
not support previous findings that inhibition of B7-H1:PD-1
signaling positively affects viral clearance, our in vivo results
suggests that B7-H1 plays a protective role during the autoimmune
phase of TMEV-IDD perhaps by limiting epitope spreading to
myelin epitopes. Our results are supported by evidence in the
experimental autoimmune encephalomyelitis (EAE) model of MS,
which indicates that B7-H1:PD-1 interactions are necessary for
protection against autoimmunity. Evidence for this conclusion
includes: (a) B7-H1
2/2 mice or mice receiving neutralizing aB7-
H1 mAb are hyper-susceptible to PLP139–151-induced relapsing
remitting EAE in SJL mice [15,16]; (b) adoptive transfer of wild-
type encephalitogenic T cells into B7-H1
2/2 recipients results in
enhanced severity of MOG35–55-induced EAE disease in C57BL/
6 mice [28]; (c) blockade of PD-1 using a neutralizing monoclonal
antibody or induction of MOG35–55-induced EAE in PD-1
2/2
mice leads to enhanced disease [29,30]; and (d) CNS-resident
microglia express constitutive and inducible levels of B7-H1 in vitro
and in vivo compared to astrocytes and splenocytes, suggesting
these cells are critical for regulation of T cell responses during
Figure 8. In vivo neutralization of B7-H1 enhances clinical
disease in chronic TMEV-IDD. Wild-type SJL/J mice were infected
with TMEV and monitored for clinical signs of disease until day 90 post
infection following 100 mg/mouse injections of aRat IgG2b isotype
control (#) and anti-B7-H1 mAb (N) at days 0 and +3 relative to
infection. The x-axis represents days post-infection, while the y-axis
represents the mean clinical score as defined in the materials and
methods. The data is representative of 3 independent experiments with
n=5 mice/group expressed as the average 6 SEM. *p,0.05 compared
to mice receiving Rat IgG2b isotype control at each time point, 2-way
ANOVA.
doi:10.1371/journal.pone.0018548.g008
Figure 9. B7-H1 limits viral replication in TMEV infection. A.
TMEV viral loads in the brain following treatment with anti-B7-H1 mAb
or isotype control at days 7 and 14 post-infection. Data are expressed as
plaque forming units/gram of tissue (PFU/g). The x-axis represents days
post-infection, while the y-axis represents PFU/g tissue. The data is
representative of 2 independent experiments with n=2–4/group
expressed as the average 6 SEM.
doi:10.1371/journal.pone.0018548.g009
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neutralization of B7-H1 affects the production of IFN-c, IL-17,
and IL-2 from CD4
+ T cells and IFN-c, IL-10, IL-2 from CD8
+ T
cells ex vivo and the substantial increase in production of these
cytokines does lead to a substantial protective effect on TMEV-
IDD development in the absence of B7-H1 signaling.
In summary, our data support the conclusion that CNS
expression of B7-H1 by CNS APCs, including microglia and
infiltrating CD11b
+CD11c
2 and CD11b
+CD11c
+ cells as well as
B7-H1 and PD-1 expression by CNS-infiltrating T cells regulates
production of IFN-c, IL-17, and IL-2. In terms of development of
TMEV-IDD, in vivo monoclonal antibody blockade of B7-H1:PD-1
signaling does not significantly alter the onset of disease, only the
severity observed during the autoimmune phase. These findings
support the idea that B7-H1:PD-1signalingmay serve as a potential
mechanism that regulates APC:T cell interactions affecting the
progression of virus-induced demyelination and autoimmunity.
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